Liaoning Cheng Da joins queue for HK biotech IPOs
Shanghai-listed Liaoning Cheng Da plans to list its biotechnology arm in Hong Kong, according to the company.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts